All News

Dispensing naloxone provides an example of how small changes can make a significant difference.

Lisa Schwartz, PharmD, RPh, senior director of Professional Affairs at NCPA, discusses the Drug Supply Chain Security Act and why it was updated for the distribution of naloxone.

Currently available agents may reduce the need for stem cell transplantation in patients with acute lymphocytic leukemia.

Loosened restrictions will likely create a more pronounced influenza season this fall.

CDC Director Rochelle Walensky, MD, MPH, announced new preferential flu vaccine recommendations for individuals aged 65 years and older.

Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.

The FDA approved the only companion diagnostic that is indicated to assess low levels of HER2 proteins in patients with metastatic breast cancer.

Are you curious about what other pharmacists earn or how satisfied they are in their jobs?

As pharmacy moves in the direction of patient-centered care, immunization plays a key role in this shift.

Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at NCPA, discussed the importance of continue education for pharmacists.

With a trained representative focused on building relationships with prescribers in the community, pharmacies have the opportunity to significantly expand how they do business.

Through gamification and food-focused activities, pharmacists can incentivize patient engagement in these services, even if offered outside the pharmacy.

Carlie Traylor, PharmD, director of Strategic Initiatives and Student Affairs at NCPA discussed the growing roles of pharmacists and pharmacy technicians and how COVID-19 has changed the landscape of services offered in community pharmacies.

Kyle McCormick, PharmD, owner of Blueberry Pharmacy, discusses the differences between a traditional pharmacy model and a cost-plus pharmacy model.

Understanding long-term frailty trajectories with kidney function measures could help prevent worse adverse health outcomes in older patients.

Bulevirtide is a synthetic myristoylated peptide derived from the pre-S1 domain of the hepatitis B virus large surface protein.

As pharmacy conglomerates race toward controlling patient journey, community pharmacist role remains murky.

Two recent clinical trials highlight the novel therapy options available to patients in the upfront and relapsed settings.

October is a time to acknowledge the powerful impact pharmacists and pharmacy technicians make on patients and communities.

An integrative efficacy score would incorporate the depth, duration, and prevalence of tumor response.

Tripp Logan, PharmD, vice president at SEMO Rx Pharmacies and Logan & Seiler Inc discusses how pharmacy staff and community health care workers can work together to address social determinants of health.

Bri Morris, PharmD, senior director of Education and the Long-Term Care Division at the National Community Pharmacists Association, discusses the importance of teamwork in the pharmacy.

The history of targeting neuroinflammation is a good example of the challenges to finding a treatment for Alzheimer disease.

Thanks to its diverse patient population and unique culture, studying pharmacy in Hawaii provides interesting experiences with culturally competent care.

Motivational interviewing is an evidence-based method of communicating with patients who are ambivalent or resistant to change for the sake of their health.

The value proposition for point-of-care testing in the pharmacy is extensive, as pharmacies can provide a convenient, accessible, and cost-saving alternative for patients.

Mosunetuzumab showed promising results in complete response rate in patients with follicular lymphoma.

Futibatinib (Lytgobi, Taiho Oncology, Inc) is indicated for adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements.

Women Pharmacist Day takes place October 12th, 2022.

Oncology pharmacists participate significantly in conversations, research, and publications of that research.